MDT
insider transactionsMedtronic plc — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
-4.2K
0 buy · 4.2K sell
Net value · 90d
-$337.0K
$0 in · $337.0K out
Sentiment · 90d
Net selling
0% buying · 100% selling
Open-market trades · 90d
2
0 buy · 4.2K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Sell·S
Harry Skip Kiil KEY
EVP & President Cardiovascular
$18.3K
228 sh · $80.45
Own -1%
-
Sell·S
Harry Skip Kiil KEY
EVP & President Cardiovascular
$318.6K
4.0K sh · $80.44
Own -10%
-
Other·F
Chief Accounting Officer
$19.7K
237 sh · $83.32
Own -2%
-
Other·F
SVP, Chief HR Officer
$236.6K
2.8K sh · $83.32
Own -7%
-
Other·F
Geoffrey Martha KEY
Chairman and CEO
$3.5M
41.9K sh · $83.32
Own -12%
-
Other·F
EVP, Pres MedSurg and Americas
$622.5K
7.5K sh · $83.32
Own -11%
-
Other·F
Harry Skip Kiil KEY
EVP & President Cardiovascular
$568.0K
6.8K sh · $83.32
Own -14%
-
Exercise·M
SVP, Chief HR Officer
$0
8.4K sh
Own New
-
Exercise·M
SVP, Chief HR Officer
$0
9.1K sh
Own +28%
-
Exercise·M
EVP & Pres Neuroscience
$0
24.2K sh
Own New
-
Exercise·M
EVP & Pres Neuroscience
$0
26.9K sh
Own +49%
-
Exercise·M
Geoffrey Martha KEY
Chairman and CEO
$0
85.5K sh
Own New
-
Exercise·M
Geoffrey Martha KEY
Chairman and CEO
$0
95.0K sh
Own +38%
-
Exercise·M
EVP, Pres MedSurg and Americas
$0
17.1K sh
Own New
-
Exercise·M
EVP, Pres MedSurg and Americas
$0
19.0K sh
Own +37%
-
Exercise·M
Harry Skip Kiil KEY
EVP & President Cardiovascular
$0
14.5K sh
Own New
-
Exercise·M
Harry Skip Kiil KEY
EVP & President Cardiovascular
$0
15.2K sh
Own +46%
-
Exercise·M
Chief Accounting Officer
$0
1.6K sh
Own New
-
Exercise·M
Chief Accounting Officer
$0
1.7K sh
Own +13%
-
Other·F
SVP, Chief HR Officer
$2.8K
35 sh · $80.00
Own -0%
-
Other·F
Director
$17.0K
207 sh · $81.90
Own -1%
-
Other·F
Director
$17.0K
207 sh · $81.90
Own -0%
-
Other·F
Director
$17.0K
207 sh · $81.90
Own -2%
-
Other·F
Director
$17.0K
207 sh · $81.90
Own -3%
-
Other·F
Director
$17.0K
207 sh · $81.90
Own -3%
-
Other·F
Director
$17.0K
207 sh · $81.90
Own -1%
-
Other·F
Chief Accounting Officer
$26.0K
318 sh · $81.90
Own -2%
-
Grant·A
Director
$0
2.1K sh
Own +12%
-
Grant·A
Director
$0
2.1K sh
Own +4%
-
Grant·A
Director
$0
2.1K sh
Own +26%
-
Grant·A
Director
$0
2.1K sh
Own +55%
-
Grant·A
Director
$0
1.8K sh
Own New
-
Grant·A
Director
$0
1.4K sh
Own +29%
-
Grant·A
Director
$0
1.4K sh
Own New
-
Grant·A
Director
$0
2.1K sh
Own +37%
-
Grant·A
Director
$0
2.1K sh
Own +10%
-
Grant·A
Chief Accounting Officer
$0
1.5K sh
Own +12%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 8, 2026 | Harry Skip Kiil KEY | Sell S | 228 | $18.3K |
| Jun 8, 2026 | Harry Skip Kiil KEY | Sell S | 4.0K | $318.6K |
| Jun 5, 2026 | Denise L. Blomquist | Other F | 237 | $19.7K |
| Jun 4, 2026 | Matthew R. Walter | Other F | 2.8K | $236.6K |
| Jun 4, 2026 | Geoffrey Martha KEY | Other F | 41.9K | $3.5M |
| Jun 4, 2026 | Michael Marinaro | Other F | 7.5K | $622.5K |
| Jun 4, 2026 | Harry Skip Kiil KEY | Other F | 6.8K | $568.0K |
| May 26, 2026 | Matthew R. Walter | Exercise M | 8.4K | $0 |
| May 26, 2026 | Matthew R. Walter | Exercise M | 9.1K | $0 |
| May 26, 2026 | Brett A. Wall | Exercise M | 24.2K | $0 |
| May 26, 2026 | Brett A. Wall | Exercise M | 26.9K | $0 |
| May 26, 2026 | Geoffrey Martha KEY | Exercise M | 85.5K | $0 |
| May 26, 2026 | Geoffrey Martha KEY | Exercise M | 95.0K | $0 |
| May 26, 2026 | Michael Marinaro | Exercise M | 17.1K | $0 |
| May 26, 2026 | Michael Marinaro | Exercise M | 19.0K | $0 |
| May 26, 2026 | Harry Skip Kiil KEY | Exercise M | 14.5K | $0 |
| May 26, 2026 | Harry Skip Kiil KEY | Exercise M | 15.2K | $0 |
| May 26, 2026 | Denise L. Blomquist | Exercise M | 1.6K | $0 |
| May 26, 2026 | Denise L. Blomquist | Exercise M | 1.7K | $0 |
| May 1, 2026 | Matthew R. Walter | Other F | 35 | $2.8K |
| Apr 28, 2026 | Elizabeth G Nabel | Other F | 207 | $17.0K |
| Apr 28, 2026 | Kendall J Powell | Other F | 207 | $17.0K |
| Apr 28, 2026 | Kevin E Lofton | Other F | 207 | $17.0K |
| Apr 28, 2026 | Gregory P Lewis | Other F | 207 | $17.0K |
| Apr 28, 2026 | Lidia Fonseca | Other F | 207 | $17.0K |
| Apr 28, 2026 | Scott C Donnelly | Other F | 207 | $17.0K |
| Apr 28, 2026 | Denise L. Blomquist | Other F | 318 | $26.0K |
| Apr 27, 2026 | Elizabeth G Nabel | Grant A | 2.1K | $0 |
| Apr 27, 2026 | Kendall J Powell | Grant A | 2.1K | $0 |
| Apr 27, 2026 | Kevin E Lofton | Grant A | 2.1K | $0 |
| Apr 27, 2026 | Gregory P Lewis | Grant A | 2.1K | $0 |
| Apr 27, 2026 | Joon Sup Lee | Grant A | 1.8K | $0 |
| Apr 27, 2026 | William R Jellison | Grant A | 1.4K | $0 |
| Apr 27, 2026 | John P Groetelaars | Grant A | 1.4K | $0 |
| Apr 27, 2026 | Lidia Fonseca | Grant A | 2.1K | $0 |
| Apr 27, 2026 | Scott C Donnelly | Grant A | 2.1K | $0 |
| Apr 27, 2026 | Denise L. Blomquist | Grant A | 1.5K | $0 |
About MDT insider trading
This page tracks insider transactions for Medtronic plc (MDT) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.